[go: up one dir, main page]

DE60013093D1 - Methoden und kits zum sequenzieren von polypeptiden - Google Patents

Methoden und kits zum sequenzieren von polypeptiden

Info

Publication number
DE60013093D1
DE60013093D1 DE60013093T DE60013093T DE60013093D1 DE 60013093 D1 DE60013093 D1 DE 60013093D1 DE 60013093 T DE60013093 T DE 60013093T DE 60013093 T DE60013093 T DE 60013093T DE 60013093 D1 DE60013093 D1 DE 60013093D1
Authority
DE
Germany
Prior art keywords
methods
kits
present disclosure
sequencing polypeptides
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60013093T
Other languages
English (en)
Other versions
DE60013093T2 (de
Inventor
Woods Keough
Scott Youngquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE60013093D1 publication Critical patent/DE60013093D1/de
Publication of DE60013093T2 publication Critical patent/DE60013093T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C07K1/128—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general sequencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6818—Sequencing of polypeptides
    • G01N33/6824—Sequencing of polypeptides involving N-terminal degradation, e.g. Edman degradation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60013093T 1999-01-20 2000-01-12 Methoden und kits zum sequenzieren von polypeptiden Expired - Fee Related DE60013093T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11650299P 1999-01-20 1999-01-20
US116502P 1999-01-20
US15667799P 1999-09-29 1999-09-29
US156677P 1999-09-29
PCT/US2000/000790 WO2000043792A2 (en) 1999-01-20 2000-01-12 Methods and kits for sequencing polypeptides

Publications (2)

Publication Number Publication Date
DE60013093D1 true DE60013093D1 (de) 2004-09-23
DE60013093T2 DE60013093T2 (de) 2005-09-01

Family

ID=26814315

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60013093T Expired - Fee Related DE60013093T2 (de) 1999-01-20 2000-01-12 Methoden und kits zum sequenzieren von polypeptiden

Country Status (12)

Country Link
EP (1) EP1145012B1 (de)
JP (1) JP2002535659A (de)
CN (1) CN1149398C (de)
AT (1) ATE274190T1 (de)
AU (1) AU757356B2 (de)
CA (1) CA2359163C (de)
DE (1) DE60013093T2 (de)
DK (1) DK1145012T3 (de)
ES (1) ES2223463T3 (de)
IL (2) IL144129A0 (de)
NO (1) NO20013563L (de)
WO (1) WO2000043792A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001270941A1 (en) 2000-06-09 2001-12-17 Mds Proteomics, Inc. Labeling of proteomic samples during proteolysis for quantitation and sample multiplexing
US20060141632A1 (en) * 2000-07-25 2006-06-29 The Procter & Gamble Co. New methods and kits for sequencing polypeptides
US7045296B2 (en) * 2001-05-08 2006-05-16 Applera Corporation Process for analyzing protein samples
JP2005518521A (ja) * 2001-05-23 2005-06-23 アメルシャム・バイオサイエンシーズ・アクチボラグ 固体支持体を用いるペプチド分析
US7074570B2 (en) 2001-05-23 2006-07-11 Ge Healthcare Bio-Sciences Ab Peptide fragmentation
JP3534191B1 (ja) * 2002-12-26 2004-06-07 日本電気株式会社 質量分析法を利用するペプチドｃ末端アミノ酸配列解析方法
US7371514B2 (en) 2004-07-16 2008-05-13 Agilent Technologies, Inc. Serial derivatization of peptides for de novo sequencing using tandem mass spectrometry
JP4543929B2 (ja) * 2005-01-04 2010-09-15 日本電気株式会社 タンパク質の解析方法
GB0503411D0 (en) * 2005-02-18 2005-03-30 Shimadzu Res Lab Europe Ltd Mass spectrometry precursor ion selection
HRP20100044B1 (hr) * 2010-01-25 2016-11-18 Institut Ruđer Bošković Metoda identifikacije proteina spektrometrijom masa
EP2710380B1 (de) * 2011-05-18 2017-06-28 Rudjer Boskovic Institute Detektionsverfahren von aminosäuresequenz und/oder identifikation von peptiden und proteinen mittels eines derivatisierungsreagenz und synthese von 5-formylbenzen-1,3-disulfonsäure als derivatisierungsreagenz
CN103852513B (zh) * 2012-11-29 2016-01-06 中国科学院计算技术研究所 一种基于hcd与etd质谱图的肽段从头测序方法及系统
CN108440740B (zh) * 2018-02-14 2020-05-05 苏州大学 一种可逆自修复环氧树脂及其制备与回收重塑方法

Also Published As

Publication number Publication date
WO2000043792A3 (en) 2000-11-30
CA2359163A1 (en) 2000-07-27
ATE274190T1 (de) 2004-09-15
ES2223463T3 (es) 2005-03-01
CN1149398C (zh) 2004-05-12
IL144129A (en) 2006-12-31
DK1145012T3 (da) 2004-12-13
CN1340162A (zh) 2002-03-13
NO20013563L (no) 2001-09-18
AU757356B2 (en) 2003-02-20
DE60013093T2 (de) 2005-09-01
NO20013563D0 (no) 2001-07-18
AU2848700A (en) 2000-08-07
WO2000043792A2 (en) 2000-07-27
CA2359163C (en) 2004-07-20
EP1145012B1 (de) 2004-08-18
EP1145012A2 (de) 2001-10-17
IL144129A0 (en) 2002-05-23
JP2002535659A (ja) 2002-10-22

Similar Documents

Publication Publication Date Title
WO2002008767A3 (en) Methods and kits for sequencing polypeptides
ATE334391T1 (de) Isolierung und analyse von proteinen
ATE274190T1 (de) Methoden und kits zum sequenzieren von polypeptiden
ATE344456T1 (de) Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE332368T1 (de) Selektion von proteinen mittels rns-protein fusionen
DE69534235D1 (de) Cytokin lerk-7
DE69735445D1 (de) Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
WO2004037999A3 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
ATE437652T1 (de) Verwendung von hmgb1 zur aktivierung dendritischer zellen
ATE227739T1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
DE60233870D1 (de) Peptidfragmentation
ATE441115T1 (de) Markierungsreagens und anwendungsverfahren
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
WO1999030165A3 (en) Processes for identifying a solvent condition suitable for determining a biophysical property of a protein
ATE225942T1 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
ATE288589T1 (de) Verfahren zur analyse von proteinen
ATE306666T1 (de) Verfahren zur eiweissanalyse
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
ES2185652T3 (es) Oligopeptidos derivados de fragmentos de proteinas c-reactiva.
AU2003260546A8 (en) Device for the presentation of peptides or proteins, method for the preparation and use thereof
NO20016340L (no) Hodetraumeindusert cytoplasmatisk kalsiumbindende protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee